Nuance Medical Acquires BIOCORNEUM Brand from Sientra
May 4, 2024
Nuance Medical has acquired the BIOCORNEUM silicone gel scar treatment brand from Sientra; the brand will be integrated into Nuance’s Biodermis portfolio effective immediately. The deal expands Biodermis’ medical-grade silicone scar management offerings and aims to strengthen product availability and support for healthcare professionals.
- Buyers
- Nuance Medical
- Targets
- BIOCORNEUM
- Sellers
- Sientra
- Industry
- Medical Devices
- Location
- Nevada, United States
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.